Bio-Techne
JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More
Highlights of the third day included Quest's view on its information and services business and Quidel's take on the proposed Ortho Clinical buy.
360Dx Index Rises 20 Percent in 2021
Several key players in the diagnostics industry saw their share prices increase by more than half, although others saw significant downturns.
Bio-Techne Fiscal Q1 Revenues Rise 26 Percent
Revenues from the Diagnostics and Genomics segment rose 22 percent and Protein Sciences segment revenues rose 28 percent year over year.
Broader Markets Lift 360Dx Index 3 Percent in October
Of the 29 companies in the index, 14 saw increases in their stock prices, while 15 saw declines.
Bio-Techne Q4 Revenues Jump 47 Percent
The firm's Diagnostics and Genomics revenues rose 38 percent to $67.1 million for the fourth quarter and rose 23 percent to $227.7 million for fiscal 2021.